Revolution Medicines, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
RVMD, RVMDW on Nasdaq
Location
700 Saginaw Dr, Redwood City, CA

Insiders trading volume in the past year

Revolution Medicines, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Thilo Schroeder Director $350M +$60M +20.7% Dec 5, 2024
Third Rock Ventures III, L.P. 10%+ Owner $138M Jun 8, 2022
Alexis Borisy Director $89.9M Jun 20, 2024
Stephen Michael Kelsey President, Research and Development $11.8M -$6.73M -36.3% Dec 16, 2024
Margaret Horn Chief Operating Officer $5.81M -$3.97M -40.6% Dec 16, 2024
Jack Anders Chief Financial Officer $4.38M -$1.23M -22% Dec 16, 2024
Sandra Horning Director $3.59M Jun 20, 2024
Lorence H. Kim Director $2.69M Jun 20, 2024
Wei Lin Chief Medical Officer $2.65M -$209K -7.31% Jun 17, 2024
Xiaolin Wang Officer $2.28M Mar 1, 2024
Jeff Cislini General Counsel $1.89M -$1.36M -41.9% Dec 16, 2024
Elizabeth M. Anderson Director $1.81M Jun 20, 2024
Neil Exter Director $1.32M Jun 16, 2022
Sushil Patel Director $1.08M -$445K -29.2% Oct 31, 2024
Flavia Borellini Director $842K Jun 20, 2024
Vincent A. Miller Director $641K Jun 22, 2021
Barbara Weber Director $627K -$250K -28.5% Oct 8, 2024
Eric Schmidt Director $574K Jun 8, 2023
Mark A. Goldsmith President and Chief Executive Officer, Director $403K -$10.5M -96.3% Dec 18, 2024
Third Rock Ventures II, L.P. 10%+ Owner $349K Jun 3, 2021
Frank Clyburn Director $322K Aug 5, 2024

Recent Insider Transactions by Companies or Individuals for Revolution Medicines, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.